{"cdcTestId":"2013-0608","testcaseName":"Dose 1 PCV 13 to dose 2 interval 28 days","vaccineGroup":"PCV","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2023-01-21T00:00:00","pastDueDate":"2023-03-20T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-01-04T10:05:29.823","generalDescription":"This test case describes when dose #1 to dose #2 of the Pneumococcal 13 vaccine is administered at an interval of 28 days, that the second dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}